









Mercado
/
Acciones
/
nasdaq-cnmd
/

Conmed Corp

CNMD

44.710USD

+0.760+1.73%

Cierre 11/11, 16:00（ET）Cotizaciones retrasadas 15 min

1.38BCap. mercado

21.60P/E TTM



Conmed Corp

44.710

+0.760+1.73%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Conmed Corp Compañía

CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Información de Conmed Corp



Símbolo de cotizaciónCNMD

Nombre de la empresaConmed Corp

Fecha de salida a bolsaJul 23, 1987

Director ejecutivoMr. Patrick J. (Pat) Beyer

Número de empleados3900

Tipo de seguridadOrdinary Share

Fin del año fiscalJul 23

Dirección11311 Concept Boulevard

CiudadLARGO

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal33773

Teléfono17272142974

Sitio Webhttps://www.conmed.com/

Símbolo de cotizaciónCNMD

Fecha de salida a bolsaJul 23, 1987

Director ejecutivoMr. Patrick J. (Pat) Beyer

Ejecutivos de Conmed Corp



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. David M. Bronson

Independent Director

17.24K

+2.86%

Mr. Stephan Epinette

Vice President and General Manager, International

15.51K

Mr. Patrick J. (Pat) Beyer

President, Chief Executive Officer, Director

10.81K

Mr. Brian P. Concannon

Independent Director

10.12K

+4.97%

Ms. Barbara J. Schwarzentraub

Independent Director

5.79K

+9.03%

Mr. Peter K Shagory

Executive Vice President - Strategy and Corporate Development

3.90K

+5.01%

Ms. Hollie Foust

Executive Vice President, General Counsel and Corporate Secretary

2.89K

Mr. Brent Lalomia

Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations

1.13K

+18.20%

Mr. Kim Kelderman

Independent Director

Mr. Richard Glaze

Chief Information Officer

-100.00%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. David M. Bronson

Independent Director

17.24K

+2.86%

Mr. Stephan Epinette

Vice President and General Manager, International

15.51K

Mr. Patrick J. (Pat) Beyer

President, Chief Executive Officer, Director

10.81K

Mr. Brian P. Concannon

Independent Director

10.12K

+4.97%

Ms. Barbara J. Schwarzentraub

Independent Director

5.79K

+9.03%

Mr. Peter K Shagory

Executive Vice President - Strategy and Corporate Development

3.90K

+5.01%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

General Surgery

201.61M

58.89%

Orthopedic Surgery

140.73M

41.11%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

190.61M

55.68%

Europe & Middle East & Africa

63.92M

18.67%

Asia Pacific

42.07M

12.29%

Americas (excluding the United States)

31.88M

9.31%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

General Surgery

201.61M

58.89%

Orthopedic Surgery

140.73M

41.11%

Estadísticas de accionistas

Actualizado: vie., 26 de sep

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

14.30%

The Vanguard Group, Inc.

11.63%

EARNEST Partners, LLC

9.14%

Fuller & Thaler Asset Management Inc.

5.62%

Capital Research Global Investors

5.41%

Otro

53.90%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

14.30%

The Vanguard Group, Inc.

11.63%

EARNEST Partners, LLC

9.14%

Fuller & Thaler Asset Management Inc.

5.62%

Capital Research Global Investors

5.41%

Otro

53.90%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

65.04%

Investment Advisor/Hedge Fund

42.43%

Hedge Fund

4.59%

Research Firm

3.29%

Pension Fund

1.91%

Bank and Trust

0.68%

Individual Investor

0.59%

Sovereign Wealth Fund

0.06%

Venture Capital

0.05%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

643

36.52M

117.92%

-5.77M

2025Q2

651

35.90M

115.99%

-5.38M

2025Q1

664

36.95M

119.42%

-4.31M

2024Q4

649

36.65M

118.59%

-2.95M

2024Q3

644

35.57M

115.39%

-3.57M

2024Q2

660

37.07M

120.35%

-1.36M

2024Q1

657

36.04M

117.06%

-2.92M

2023Q4

642

36.87M

119.89%

-1.61M

2023Q3

624

36.40M

118.42%

-2.31M

2023Q2

606

36.19M

118.37%

-3.41M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

4.43M

14.3%

-133.34K

-2.92%

Jun 30, 2025

The Vanguard Group, Inc.

3.54M

11.44%

+42.41K

+1.21%

Jun 30, 2025

EARNEST Partners, LLC

2.83M

9.14%

+30.22K

+1.08%

Jun 30, 2025

Fuller & Thaler Asset Management Inc.

1.74M

5.62%

+566.60K

+48.26%

Jun 30, 2025

Capital Research Global Investors

1.68M

5.41%

+2.76K

+0.16%

Jun 30, 2025

Managed Account Advisors LLC

1.38M

4.47%

+103.77K

+8.11%

Jun 30, 2025

State Street Investment Management (US)

1.29M

4.18%

-8.83K

-0.68%

Jun 30, 2025

Westwood Management Corp. (Texas)

1.24M

-484.00

-0.04%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

1.08M

3.5%

+184.21K

+20.50%

Jun 30, 2025

Macquarie Investment Management

969.64K

3.13%

+16.21K

+1.70%

Jun 30, 2025

ETFs relacionados



Actualizado: jue., 6 de nov

Nombre

Proporción

SPDR S&P Health Care Equipment ETF

1.46%

ROBO Global Healthcare Technology & Innovation ETF

1.14%

Invesco S&P SmallCap Health Care ETF

0.93%

Harbor Human Capital Factor US Small Cap ETF

0.59%

VictoryShares Small Cap Free Cash Flow ETF

0.35%

iShares US Small Cap Value Factor ETF

0.34%

First Trust Small Cap Value AlphaDEX Fund

0.3%

WisdomTree US SmallCap Quality Dividend Growth

0.26%

Lattice Hartford Multifactor Small Cap ETF

0.23%

Royce Quant Small-Cap Quality Value ETF

0.23%

SPDR S&P Health Care Equipment ETF

Proporción1.46%

ROBO Global Healthcare Technology & Innovation ETF

Proporción1.14%

Invesco S&P SmallCap Health Care ETF

Proporción0.93%

Harbor Human Capital Factor US Small Cap ETF

Proporción0.59%

VictoryShares Small Cap Free Cash Flow ETF

Proporción0.35%

iShares US Small Cap Value Factor ETF

Proporción0.34%

First Trust Small Cap Value AlphaDEX Fund

Proporción0.3%

WisdomTree US SmallCap Quality Dividend Growth

Proporción0.26%

Lattice Hartford Multifactor Small Cap ETF

Proporción0.23%

Royce Quant Small-Cap Quality Value ETF

Proporción0.23%

Dividendos



Un total de 119.19M USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Feb 25, 2025

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 04, 2025 going ex on Mar 14, 2025

Mar 14, 2025

Apr 04, 2025

Mar 14, 2025

Dec 10, 2024

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 03, 2025 going ex on Dec 20, 2024

Dec 20, 2024

Jan 03, 2025

Dec 20, 2024

Aug 09, 2024

CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 04, 2024 going ex on Sep 16, 2024

Sep 16, 2024

Oct 04, 2024

Sep 16, 2024

May 22, 2024

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2024 going ex on Jun 14, 2024

Jun 14, 2024

Jul 05, 2024

Jun 14, 2024

Feb 26, 2024

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2024 going ex on Mar 14, 2024

Mar 15, 2024

Apr 05, 2024

Mar 14, 2024

Dec 05, 2023

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2024 going ex on Dec 15, 2023

Dec 18, 2023

Jan 05, 2024

Dec 15, 2023

Aug 10, 2023

CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 05, 2023 going ex on Sep 14, 2023

Sep 15, 2023

Oct 05, 2023

Sep 14, 2023

May 24, 2023

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2023 going ex on Jun 14, 2023

Jun 15, 2023

Jul 05, 2023

Jun 14, 2023

Feb 27, 2023

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2023 going ex on Mar 14, 2023

Mar 15, 2023

Apr 05, 2023

Mar 14, 2023

Dec 05, 2022

CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2023 going ex on Dec 15, 2022

Dec 16, 2022

Jan 05, 2023

Dec 15, 2022

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

